Cargando…
CRISPR Interference-Based Inhibition of MAB_0055c Expression Alters Drug Sensitivity in Mycobacterium abscessus
There is an unmet medical need for effective treatments against Mycobacterium abscessus infections. Although advanced molecular genetic tools to validate drug targets and resistance of M. abscessus exist, the practical design and construction of plasmids are relatively laborious and time-consuming....
Autores principales: | Nguyen, Thanh Quang, Heo, Bo Eun, Park, Yujin, Jeon, Seunghyeon, Choudhary, Arunima, Moon, Cheol, Jang, Jichan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269454/ https://www.ncbi.nlm.nih.gov/pubmed/37158736 http://dx.doi.org/10.1128/spectrum.00631-23 |
Ejemplares similares
-
Omadacycline Potentiates Clarithromycin Activity Against Mycobacterium abscessus
por: Bich Hanh, Bui Thi, et al.
Publicado: (2021) -
Current Molecular Therapeutic Agents and Drug Candidates for Mycobacterium abscessus
por: Quang, Nguyen Thanh, et al.
Publicado: (2021) -
A Screening of the MMV Pandemic Response Box Reveals Epetraborole as A New Potent Inhibitor against Mycobacterium abscessus
por: Kim, Taeho, et al.
Publicado: (2021) -
Pathogen Box screening for hit identification against Mycobacterium abscessus
por: Jeong, Jinsun, et al.
Publicado: (2018) -
Characterization of the cluster MabR prophages of Mycobacterium abscessus and Mycobacterium chelonae
por: Cote, Jacob, et al.
Publicado: (2022)